Initially identified as a tumor-suppressor gene with apoptosis-inducing activities in prostate cancer, GLIPR1 pleiotropic effects have been reported to be highly expressed and upregulated, and it acts as an oncogene specifically in glioblastomas and gliomas, thus promoting cell proliferation[127,130,131]. The gene discussed is GLIPR1; the disease is glioma.